CCR5 Chemokine Receptor Mediates Recruitment of MHC Class II-Positive Langerhans Cells in the Mouse Corneal Epithelium by Yamagami, Satoru et al.
CCR5 Chemokine Receptor Mediates
Recruitment of MHC Class II-
Positive Langerhans Cells in
the Mouse Corneal Epithelium
The Harvard community has made this
article openly available.  Please share  how
this access benefits you. Your story matters
Citation Yamagami, Satoru, Pedram Hamrah, Kazuhisa Miyamoto, Dai
Miyazaki, Iva Dekaris, Tracey Dawson, Bao Lu, Craig Gerard, and M.
Reza Dana. 2005. “CCR5 Chemokine Receptor Mediates Recruitment
of MHC Class II-Positive Langerhans Cells in the Mouse Corneal
Epithelium.” Investigative Opthalmology & Visual Science 46 (4)
(April 1): 1201. doi:10.1167/iovs.04-0658.
Published Version 10.1167/iovs.04-0658
Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:34428291
Terms of Use This article was downloaded from Harvard University’s DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at http://
nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-
use#LAA
CCR5 Chemokine Receptor Mediates Recruitment of
MHC Class II-Positive Langerhans Cells in the Mouse
Corneal Epithelium
Satoru Yamagami,1,2 Pedram Hamrah,1 Kazuhisa Miyamoto,1 Dai Miyazaki,1
Iva Dekaris,1 Tracey Dawson,3 Bao Lu,4 Craig Gerard,4 and M. Reza Dana1
PURPOSE. To characterize the chemokines and chemokine re-
ceptors that mediate the effect of proinflammatory cytokines,
interleukin (IL)-1 and tumor necrosis factor (TNF)-, on the
recruitment of MHC class II Langerhans cells (LCs) in the
corneal epithelium.
METHODS. A standard model for corneal LC recruitment, appli-
cation of cautery to the central corneal surface was used, and
the differential gene expression levels of a panel of chemo-
kines and chemokine receptors were determined by RNase
protection assay. Chemokine receptor-knockout mice were
used to evaluate the recruitment of MHC class II LCs to the
corneal epithelium. To determine the sensitivity of selected
chemokines to IL-1 and TNF- stimulation, the chemokine
gene expression pattern was analyzed after blockade of IL-1
and TNF receptors.
RESULTS. CCR1, -2, and -5 were overexpressed in corneas after
cauterization. Topical administration of soluble TNF receptor I
and IL-1 receptor antagonist, which abrogated corneal LC re-
cruitment, significantly suppressed the gene transcription lev-
els of the ligands of CCR1 and/or -5, regulated on activation
normal T-cell expressed and secreted (RANTES), macrophage
inflammatory protein (MIP)-1, and MIP-1. The recruitment
of major histocompatibility complex (MHC) class II LC was
significantly suppressed in CCR5/ mice and blockade of
RANTES and MIP-1, but not in CCR1/, CCR2//MIP-
1/, or MIP-1/ mice. The evaluation of epithelial
CD11c LC cells by confocal microscopy revealed coexpres-
sion for CCR5 primarily among B7 (CD80/CD86) subsets of
these LCs but not among the mature B7 subsets of CD11c LCs.
CONCLUSIONS. These data suggest that CCR5 plays a critical role
in mediating recruitment and mobilization of MHC class II
LCs into the corneal epithelium. Targeting CCR5 and its ligands
may be a new strategy for modulating immunity. (Invest Oph-
thalmol Vis Sci. 2005;46:1201–1207) DOI:10.1167/iovs.04-
0658
L angerhans cells (LCs) are a specialized subpopulation ofbone marrow–derived dendritic cells (DCs), which, in ad-
dition to their well-characterized function in the skin, are part
of the professional antigen-presenting cell (APC) population of
the ocular surface.1 Recent data from our laboratory have
revealed that the epithelium of the normal mouse cornea
contains both resident CD11c major histocompatibility com-
plex (MHC) class II-negative LCs as well as CD11cMHC class
II-positive LCs.2 These MHC class II LCs exist, not only in the
corneal periphery and limbus, but also exclusively in the cen-
tral and paracentral corneal epithelium,2 where MHC class II
LCs are totally absent.2–4 Although the immunologic role of
MHC class II LCs remains unknown, the critical role of MHC
class II LCs in initiating immunogenic and specifically T-cell-
mediated inflammation in the cornea and ocular surface is well
established.3,5,6
In the corneal epithelium, several inflammatory stimuli and
corneal diseases (e.g., alkali or thermal burns and infection)
have been shown to induce recruitment of MHC class II LCs
into the central cornea, where they may initiate Ag process-
ing.7–10 For example, in herpetic keratitis, migration of MHC
class II LCs into the cornea is associated with significant
exacerbation of disease.7,11 Further, the existence of MHC
class II LCs in the center of the cornea is critical in the innate
immune response to Pseudomonas aeruginosa.12 Moreover,
the microanatomic distribution of MHC class II ocular surface
LCs, specifically the fact that MHC class II cells are absent
from the central cornea, has been related to the immune
privilege of the cornea and the generally favorable prognosis of
corneal allografts.13–15 Conversely, the poor prognosis of
“high-risk” corneal allografts, where the donor tissue is en-
grafted onto inflamed and vascularized host beds, has been
associated with the significant endowment of MHC class II
corneal LCs in the transplant bed, which can facilitate allosen-
sitization.14,16 These findings suggest that the mobilization and
distribution of MHC class II LCs in the central areas of the
cornea can alter the clinical course of a variety of corneal
diseases.
Despite the critical role of LCs as “professional” APCs, the
molecular mechanisms that mediate their recruitment into
ocular tissues are only partially understood. IL-1 has been
reported to play a critical role in the recruitment of MHC class
II LCs in not only the cornea,17,18 but also the skin.19 Con-
versely, topical administration of an IL-1 receptor antagonist
(IL-1ra), a natural and potent antagonist of IL-1RI, has been
shown to suppress significantly the recruitment of MHC class
II LCs into the central cornea.5 In addition to IL-1, TNF- has
been implicated in the migration of skin LCs.20,21 Similarly, we
have shown that TNF- (through the activity of its receptors
p55 [TNFR-I] and p75 [TNFR-II]) is a critical mediator of MHC
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class II LC recruitment into the cornea and that it can partially
mediate the activity of IL-1 in recruiting corneal LCs.4 How-
ever, although animals with gene-targeted deficiency of both
p55 and p75 exhibited impaired corneal LC recruitment, we
could not uniformly detect TNFR expression by all corneal LCs
that migrated into the cornea in response to inflammation.
Therefore, we have hypothesized,4 but thus far have not pro-
vided proof, that the effect of proinflammatory cytokines on
the recruitment of MHC class II LCs is not direct, but rather
is mediated through select inducible chemokines that are gen-
erated in response to local inflammation. Herein, we provide
data, using an established experimental model of inflammatory
keratitis associated with the expression of MHC class II LCs,
that differential overexpression of select chemokines and che-
mokine receptors, notably CCR5 and its ligands, mediates the
IL-1 and TNF--induced recruitment of ocular surface MHC
class II LCs in the central corneal epithelium.
MATERIALS AND METHODS
Animals
Unless otherwise noted, BALB/c (H-2d) mice (Taconic Farm, German-
town, NY) were used for chemokine and chemokine receptor mRNA
detection studies. Gene knockout (KO) strains tested, included mice
with homozygous deficiency of CCR5 (CCR5/, C57BL/129 back-
ground from Jackson Laboratory, Bar Harbor, ME), CCR2/MIP-1/
(C57BL/129 background), MIP-1/ (C57BL/6; Jackson Laboratory),
and CCR1 (CCR1/, C57BL/129 background).22 The wild-type con-
trol animals (C57BL/129 and C57BL/6) were procured originally from
Jackson Laboratory and were subsequently bred at the Schepens Eye
Research Institute animal colony. All experiments used male mice that
were 6 to 12 weeks of age. All animals were treated in accordance with
the ARVO Statement for the Use of Animals in Ophthalmic and Vision
Research.
Antibodies
The primary antibodies (Abs), their specificity, and their respective
control Abs are summarized in Table 1. CCR1 and CCR5 Abs were
purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Regulated
on activation, normal T-cell expressed and secreted (RANTES)/CCL5,
macrophage inflammatory protein (MIP)-1/CCL4 Abs, and their iso-
type control (rat IgG2a) were obtained from R&D Systems (Minneap-
olis, MN). The other primary Abs were from BD PharMingen (San
Diego, CA). The secondary antibodies were Cy5-conjugated goat anti-
Armenian hamster IgG (BD PharMingen), and FITC- and rhodamine-
conjugated donkey anti-goat IgG and rhodamine-conjugated goat anti-
rat IgG (Santa Cruz Biotechnology).
Induction of MHC Class II LC Recruitment
and Enumeration
Mice were deeply anesthetized with an intraperitoneal injection of 3 to
4 mg ketamine and 0.1 mg xylazine and placed under the operating
microscope. Unless noted otherwise, ocular major histocompatibility
complex (MHC) class II LC recruitment into the central and paracen-
tral cornea was induced by application of thermal cautery. With the tip
of a hand-held cautery (Aaron Medical Industries Inc., St. Petersburg,
FL), seven to nine burns were applied to the surface of the central area
of the cornea to induce MHC class II LC recruitment into the corneal
epithelium, as previously described.4 Antibiotic ophthalmic ointment
was applied immediately after all eye surgeries. At select time points
after corneal cauterization (n  6–10 mice per time point), corneas
were harvested, and LC enumeration was performed in whole corneal
epithelial sheets by use of indirect immunofluorescence, as described
elsewhere.4,5 Briefly, corneas were removed and placed in 20 mM
EDTA buffer for 30 minutes at 37°C. The epithelium was detached and
washed in phosphate-buffered saline (PBS) at room temperature. After
fixation with 95% alcohol, epithelial sheets were incubated with pri-
mary anti-mouse Iad Ab for BALB/c mice, or with anti-mouse Iab Ab for
C57BL/6 or C57BL/129 mice for 30 minutes at 37°C to detect respec-
tive strain-specific MHC class II LCs. Isotype-matched control anti-
bodies and secondary antibodies alone were used as negative controls.
Epithelial sheets were washed twice in PBS and incubated with FITC-
conjugated goat anti-mouse secondary Ab for 30 minutes at 37°C.
Samples were mounted on slides and examined under the fluorescence
microscope. MHC class II LCs in the central and paracentral (central
2 mm) of the cornea were enumerated using a square ocular grid and
quantified as LCs per square millimeter.
RNA Preparation and RNase Protection Assay
At select time points after corneal surgery (n  6–10 corneas per time
point per experiment), total RNA was extracted by the single-step
method (RNA-STAT-60; Tel-Test Inc., Friendswood, TX). Briefly, whole
corneas were homogenized and centrifuged to remove cellular debris.
The RNA pellet was resuspended in nuclease-free water and processed
together as a group. Detection and quantification of murine chemokine
mRNAs were performed with a multiprobe RPA system (BD Bio-
science, Franklin Lake, NJ), as recommended by the supplier and as we
have previously described.23 Briefly, a mixture of [-32P] UTP-labeled
antisense riboprobe was generated from the chemokine template set
mCK-5 and mCR-5 (BD Bioscience). Ten micrograms of total RNA was
used in each sample. Total RNA was hybridized overnight at 56°C with
300 pg of the 32P-anti-sense riboprobe mixture. After purification by
ethanol precipitation, the samples were resolved on 5% polyacryl-
amide sequencing gels. The gels were dried and subjected to autora-
diography. Protected bands were observed after exposure of gels to
x-ray film. The bands were quantitated by densitometric analysis and
were normalized to averaged density of L32 and GAPDH.
Suppression of MHC Class II LC Recruitment
with Topical IL-1Ra and Soluble
TNFR-I Administration
To determine alterations in chemokine and chemokine receptor ex-
pression as a result of local immunotherapies that suppress ocular LC
migration, we topically applied IL-1ra (2 mg/mL; kindly provided by
TABLE 1. Primary and Respective Control Antibodies
Primary Ab (Clone) Specificity Control Ab
Iad-FITC (39-10-8) BALB/c mouse class II MHC Ag Mouse IgG-FITC
Iab-FITC (AF6-120.1) C57BL/6 or C57BL.129 mouse class II MHC Ag Mouse IgG-FITC
CD11c (HL3) Integrin DC/LC marker Hamster IgG
CD45 (30-F11) Panleukocyte marker Rat IgG2b
CD80-FITC (16-10AI) B7.1 costimulatory molecule Hamster IgG
CD86-PE (GL1) B7.2 costimulatory molecule Rat IgG2a
CCR1 (C-20) CC chemokine receptor 1 Goat IgG
CCR5 (M-20) CC chemokine receptor 5 Goat IgG
RANTES (53405) RANTES/CCL5 Rat IgG2a
MIP-1 (46907) MIP-1/CCL4 Rat IgG2a
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Ulrich Feige; Amgen Corp., Thousand Oaks, CA) and soluble (s) TNFR-I
(15 mg/mL; kindly provided by Carl Edwards, Amgen Corp.) eye drops
four times daily after cauterization until tissues were harvested. Eye
drops containing the vehicle (0.2% hyaluronic acid) were used in the
same manner as in the control mice. On days 3 and 6 after cauteriza-
tion, corneas (n  10 per time point per experiment) were removed
in both groups and homogenized (RNA-STAT-60; Tel-Test) and stored
at 70°C for RNA extraction and RPA analysis. All experiments were
repeated at least twice; representative data are presented.
Effect of MHC Class II LC Recruitment with
Subconjunctival Injection of Anti-RANTES and
MIP-1 Abs
After cautery, subconjunctival injection was performed with a 100-L
glass syringe (Hamilton Co., Reno, NV) with a 30-gauge needle. A total
of 5 L (5 g each) of rat anti-mouse RANTES and anti-mouse MIP-1
neutralized Abs was injected on the day of the cautery and 2 and 4 days
after surgery. The same amount of rat IgG2a was used as a control.
MHC class II LCs in the central and paracentral of the cornea were
enumerated on day 6.
Evaluation for CCR1 and CCR5 Cells in Corneal
Epithelial Sheets
Mice were killed on days 3 and 6 after cauterization, and corneas were
excised from BALB/c mice. Corneal epithelium sheets were removed
as described earlier and fixed in acetone for 15 minutes at room
temperature (RT). To block nonspecific staining, epithelial sheets were
incubated in 2% bovine serum albumin (BSA) diluted in PBS (PBS-BSA)
for 15 minutes before addition of primary and secondary antibodies.
Purified primary antibodies or isotype-matched control antibodies
were applied to the samples for 2 hours, followed by a 60-minute
incubation of a second FITC- or PE-conjugated primary antibody or by
incubation of the secondary antibodies for 60 minutes (all diluted for
optimal concentrations in PBS-BSA). Epithelial sheets were further
stained with secondary antibodies only, as additional controls. All
staining procedures were performed at RT, and each step was followed
by three thorough washings in PBS for 5 minutes each. Finally, epithe-
lial sheets were covered with mounting medium (Vector, Burlingame,
CA) and examined with a confocal microscope (Leica TCS 4D; Laser-
technik, Heidelberg, Germany). Epithelial sheets were examined at
160- and 400-fold magnifications using a 10 eyepiece and 16 or
40 objective lens. At least three different corneas were examined per
each double-staining experiment. In addition to detection of MHC class
II cells, corneal LCs were identified by use of anti-mouse CD11c Ab
and anti-mouse CD45 Ab.
Statistical Analysis
The Mann-Whitney test was used to compare the number of LCs in the
corneal epithelium under different experimental conditions. All exper-
iments were repeated at least twice unless noted. P  0.05 was
considered significant.
RESULTS
Differential Chemokine Gene Expressions
Associated with Corneal LC Recruitment
and Mobilization
Experimental induction of MHC class II corneal LC migration
was followed by RPA analysis to determine the upregulation of
involved chemokine and chemokine receptor genes in this
model. The results of MHC class II LC enumeration in the
central and paracentral areas of the corneal epithelium on day
6 after cauterization showed a profound increase in the num-
ber of LCs (data not shown). Figure 1 shows the results of the
chemokine RPA autoradiography, demonstrating the mRNA
quantities of chemokines normalized to averaged density of
L32 (a ribosomal protein) and GAPDH. The chemokines RAN-
TES, MIP-1, MIP-1, and MIP-2 genes were overexpressed in
cauterized corneas on both days 3 and 6 after cautery, com-
pared with expression in normal uninflamed corneas. Further,
minimal levels of eotaxin were detectable on day 3 after cau-
tery. Moreover, there was no gene expression for lymphotac-
tin, interferon- inducible protein (IP)-10, monocyte chemoat-
tractant protein (MCP)-1, and T-cell activation gene (TCA)-3 in
corneas at any of the time points studied. The striking overex-
pression of CC () chemokine ligand genes, led us to analyze
further the differential gene expression of the CC chemokine
receptors. Overexpression was observed for the chemokine
receptors CCR1, -2, and -5 (Fig. 2). In contrast, CCR1b, -3, and
-4 were not expressed in normal or cauterized corneas at any
time point.
FIGURE 1. Chemokine gene expres-
sion in the cornea after cautery. (A)
Autoradiography data. On the basis
of the migration pattern of the undi-
gested probes, specific bands were
identified for each chemokine. (B)
Densitometric analyses normalized
to L32 and GAPDH. Vertical axes in-
dicate arbitrary units based on densi-
tometry. There was overexpression
of RANTES, MIP-1, MIP-1, and
MIP-2 mRNA in corneas on days 3
and 6 after cauterization. Minimal
levels of eotaxin were detectable on
day 3 after cautery. Two sets of re-
sults on separate experiments were
analyzed, and averaged density is
shown as the results of densitometric
analysis.
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Suppression of LC Migration by IL-1R Antagonist
and Soluble TNF Receptor (R) I
We have shown that the blockade of IL-1 or TNF- function
(through receptor blockade or gene knockout strategies) can
suppress the recruitment of MHC class II LCs to the central
corneal epithelium.4,5,16,24 In this set of experiments we ap-
plied topical sTNFR-I and/or IL-1ra to corneas, to suppress the
local IL-124 and TNF-25 activity. The application of sTNFR-I
alone to cauterized corneas led to a 40% and 47% reduction in
the number of MHC class II LCs in the central cornea, by 1
and 2 weeks after cautery, respectively, compared with vehicle
controls (P  0.01;data not shown). However, the simulta-
neous blockade of both TNF- and IL-1 through the combined
application of IL-1ra and sTNFR-I led to an undetectable num-
ber of MHC class II LCs in the corneas, suggesting the abro-
gation of LC migration into the cornea (P  0.001; data not
shown). To evaluate further the effect of the topical immuno-
modulatory strategies used in the study on chemokine expres-
sion, treated corneas were harvested, and chemokine gene
expression assayed on days 3 and 6 after administration of
IL-1ra and sTNFR-I (or control vehicle) subsequent to tissue
cauterization. Figure 3 shows the results of the chemokine RPA
autoradiography and their densitometric analyses normalized
to averaged density of L32 and GAPDH. RANTES; eotaxin; and
MIP-1, -1, and -2 mRNAs were all expressed abundantly on
day 3 in both the treated and the placebo groups. However,
whereas the genes of RANTES, MIP-1, and MIP-1 were still
expressed at day 6 in the placebo group, corneas treated with
IL-1ra and sTNFR-I demonstrated no or minimal levels of gene
expression for these chemokines. Treatment with IL-1ra and
sTNFR-I however, did not affect the expression levels of
eotaxin and MIP-2 genes at day 6.
Recruitment of MHC Class II Corneal LCs in
CCR5- and CCR1-KO Mice
To differentiate further which CCR system is more closely
associated with the recruitment of MHC class II LCs, KO mice
lacking the genes for CCR1 (CCR1/), CCR2/MIP-1
(CCR2/ MIP-1/), MIP-1 (MIP-1/), or CCR5
(CCR5/) were used to analyze the ability of ocular surface
LCs to migrate into the cornea, by enumeration of MHC class
II LCs in the epithelium after cautery. No significant differ-
ences in the number of MHC class II LCs was observed
between CCR1-KO, CCR2/MIP-1 double-KO, MIP-1-KO, and
respective wild-type control animals (Fig. 4A–C) after cautery.
In contrast, the number of MHC class II LCs in the central
cornea, was significantly reduced (50%) in CCR5-KO mice
compared with wild-type control mice (P  0.005) on day 6
after cautery (Fig. 4D).
Effect of MHC Class II LC Recruitment with
Subconjunctival Injection of Anti-RANTES and
MIP-1 Abs
Although RANTES, MIP-1, and MIP-1 are the ligands of CCR5
and are upregulated after cautery, MIP-1-KO mice did not
show MHC class II LCs migration (Fig. 4C). Therefore, block-
ing experiments were performed with subconjunctival injec-
tion of RANTES and MIP-1 neutralizing Abs. As shown in
Figure 5, the number of MHC class II LCs significantly de-
creased in corneal epithelia of anti-RANTES/MIP-1 Abs treat-
ment group compared with those of the isotype control group.
Expression of CD80, CD86, and MHC Class II
Antigens in CCR5 Corneal LCs
The data herein suggest that CCR5 activity is functionally
associated with an increase in MHC class II LCs and their
migration into inflamed corneas. To determine whether this
effect was mediated directly through CCR5 (i.e., at the level of
epithelial LCs) or indirectly (i.e., through a CCR5-dependent
recruitment of another leukocyte population that could in turn
lead to LC migration), we performed immunohistochemistry
on normal and inflamed corneas to evaluate the expression of
CCR5 and -1. In the normal uninflamed cornea, CD45CD11c
DCs were uniformly B7 (CD80/CD86), both in the central
epithelium and stroma, indicating their immature phenotype,
as recently described.2,26,27 In addition, analysis of normal
corneas revealed all epithelial LCs to be uniformly CCR5 and
-1, regardless of location. However, by day 6 after cautery,
CCR5 corneal LCs were observed in significant numbers in
the limbal and to a lesser degree in the peripheral corneal
FIGURE 2. CC chemokine receptor
gene expression levels were ana-
lyzed at the same time points as in
Figure 1. (A) Autoradiography data
and (B) densitometric analysis nor-
malized to GAPDH. Overexpression
of CCR1, -2, and -5 mRNA was ob-
served in corneas on both days 3 and
6 after cauterization. Two sets of re-
sults in separate experiments were
analyzed, and averaged density was
shown as the results of densitometric
analysis.
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epithelium (Figs. 6A–C). MHC class II LCs, present in large
numbers in the limbal and peripheral epithelium, were mostly
CCR5 on both days 3 (Figs. 6D, 6E) and 6 after cautery. In
inflamed corneas, LCs expressing CD80 (Fig. 6F) and CD86
(data not shown) were observed immediately adjacent to the
maximally inflamed areas around cautery sites. These B7 LCs,
however, most of which also expressed MHC class II, failed to
express CCR5, suggesting that the acquisition of maturation
markers (Ia and costimulatory factors) is associated with the
downregulation of CCR5 gene expression. Finally, epithelial
LCs in inflamed corneas were uniformly CCR1 at any of the
time points studied, although CCR1 DCs were detected in the
corneal stroma after cauterization (data not shown).
DISCUSSION
Chemokines have been subdivided into different families based
on the relative position of their cysteine residues.28 In the CC
() chemokine group, which is primarily involved in recruit-
ment of immune cells such as APCs and T cells,28,29 the first
two cysteine residues are adjacent to each other. RANTES,
eotaxin, MIP-1, MIP-1, MCP-1, and TCA3 are part of the CC
chemokine family. The CXC () chemokine family, in contrast,
which includes IP-10, IL-8, and MIP-2, has the first two cys-
FIGURE 3. Chemokine gene expression in corneas was analyzed on
days 3 and 6 after cautery under the topical administration of simulta-
neous IL-1ra and TNFRI eye drops after cauterization. (A) Chemokine
RPA autoradiography and (B) densitometric analyses normalized to
GAPDH. RANTES, eotaxin, MIP-1, MIP-1, and MIP-2 mRNA were
expressed on day 3 in both the IL-1ra- and TNFRI-treated and the
placebo groups. Although RANTES, MIP-1, and MIP-1 gene expres-
sion levels were maintained on day 6 in the placebo group, chemokine
gene expressions were suppressed in the IL-1ra- and TNFRI-treated
group. In addition, treatment with IL-1ra and TNFRI did not affect the
expression levels of eotaxin and MIP-2 genes. Two sets of results on
separate experiments were analyzed, and averaged density was shown
as the results of densitometric analysis.
FIGURE 4. Enumeration of MHC class II LCs in CCR1-, CCR2/MIP-1
double-, MIP-1-, and CCR5-KO mice. (A) No significant difference in
the number of MHC class II LCs was observed between the CCR1-KO
mice and the wild-type controls. (B) CCR5-KO mice, however, show a
significant reduction in MHC class II LCs compared with the wild-
type control mice. Two sets of results in separate experiments were
analyzed, and representative data are shown. *P  0.0074.
FIGURE 5. Enumeration of MHC class II LCs on day 6 after cauter-
ization in the corneal epithelium treated with subconjunctival injection
of anti-RANTES/MIP-1 Abs. Subconjunctival injections were per-
formed on days 0, 2, and 4. The number of MHC class II LCs
decreased significantly in the epithelium of anti-RANTES/MIP-1 Abs-
treated corneas, compared with isotype control IgG2a-treated corneas.
Positive control indicates no subconjunctival injection group after
cautery. Two sets of results on separate experiments were analyzed,
and representative data are shown. *P  0.0078.
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teines separated by one amino acid residue. Chemokines form
a complex functional network in a variety of inflammatory,
infectious, and immune-mediated diseases, both locally and
systematically. Whereas CXC chemokines (e.g., MIP-2 and
Gro-) have been shown to mediate the recruitment of neu-
trophils30 and CC chemokines, and their receptors have been
demonstrated to be critical in regulating the recruitment of
DCs, including LCs.31–37
In the present study, thermal cautery, which led to an
increase in MHC class II LCs in the central areas of the corneal
epithelium, was associated with an overexpression of the che-
mokines RANTES, MIP-1, MIP-1, eotaxin, and MIP-2, but not
IP-10, MCP-1, and lymphotactin. In addition, CCR1 (e.g.,
RANTES, MIP-1, MCP-3), CCR2 (MCP-1, -2, and -3), and CCR5
(e.g., RANTES, MIP-1, MIP-1)38,39 receptor genes, but not
CCR3 (eotaxin) or -4 (MDC) receptor genes are overexpressed
at the same time points after cautery. Because the initial data
primarily implicated the CCR1, -2, and -5 to be associated with
the increase of MHC class II LCs in the central cornea, we
further assessed the functional relevance of these CC receptors
by studying the recruitment of MHC class II LCs in CCR1-,
CCR2/MIP-1-, MIP-1-, and CCR5-KO mice compared with
respective wild-type mice. Our results revealed that MHC class
II LCs in the corneal epithelium are significantly, but not
entirely, suppressed in CCR5/ mice compared with wild-
type control animals, whereas no significant differences in
CCR1-, CCR2/MIP-1-, and MIP-1-KO are appreciated com-
pared with controls. The finding that blockade of the CCR5
ligands RANTES and MIP-1 decreased the number of MHC
class II LCs also strongly supports the functional relevance of
CCR5 in the recruitment of MHC class II LCs.
Our data further demonstrate that the resident limbal
CD11c LCs were uniformly CCR5. After corneal stimulation
with cautery, however, CCR5 LCs could be observed infiltrat-
ing the corneal periphery, indicating the direct role of CCR5 in
the recruitment of corneal LCs, extending the previously
shown role of the proinflammatory cytokines IL-1 and TNF- in
this process. These CCR5 LCs are mostly immature, whereas
most mature LCs in the cornea fail to express this receptor.
CCR5 is therefore mediating the initial migration of immature
LCs into the epithelium, and is being downregulated once
these migrated LCs reach a more mature stage in the cornea.
What we cannot determine as yet is whether the CCR5 LCs
are derived from the normally CCR5 limbal LCs that upregu-
late CCR5 in response to proinflammatory cytokines and are
than chemotactically drawn to the cornea before acquiring a
high maturation state and MHC class II expression, or whether
they represent a distinct subset of LCs or LC precursors that
express CCR5 and are recruited from the limbal intravascular
compartment in response to local inflammation in the cornea.
The conclusion that CCR5 function is associated with the
mobilization of LCs into the corneal epithelium is based on
several lines of investigation. First, promotion of LC recruit-
ment was associated with upregulation of both CCR5 and its
associated ligands. Second, the suppression of LC mobilization
by cytokine modulation was associated with suppression in
gene expression for CCR5-associated ligands; and third, dele-
tion of the CCR5 gene and blockade of its ligands RANTES and
MIP-1 led to significant suppression in LC recruitment.
We observed that the expression of CCR5, which is associ-
ated with LC migration, is inversely related to the maturational
stage of LCs. This observation is indeed well confirmed for a
variety of APC populations and chemokine receptors respon-
sible for their migration.31–34 For example, it is known that the
chemokine receptor CCR6 can initiate recruitment of imma-
ture DC subsets to inflamed peripheral sites,31,35–36 whereas
other chemokine systems (CCR7, ELC/MIP-3) can direct the
migration of mature Ag-bearing DCs from the periphery to
lymphoid organs, where they stimulate T cells1,32,34,40–42 Al-
though we do not have any data at this time that demonstrate
definitively similar switching of differential chemokine recep-
tors in corneal APCs, including LCs, it is tempting to speculate
that other chemokine systems distinct from CCR5 (and its
ligands RANTES and MIP-1) mediate the APC emigration from
the cornea to lymphoid organs.
It is important to underscore the limitations of this study.
First, we were not able to demonstrate complete suppression
of the recruitment of MHC class II LCs in CCR5-KO mice,
suggesting that other molecular pathways may also be involved
in mediating LC recruitment to the cornea. Other candidates
include CCR6 and its ligand MIP-3, which have been shown
to be involved in the recruitment of LCs into the epider-
mis.36,41 In our preliminary study, CCR6 are expressed in the
normal mouse corneal epithelium under a confocal micro-
scope and blockade of CCR6 neutralized Ab with subconjunc-
tival injection partially suppressed the recruitment of MHC
class II LCs (Yamagami S, unpublished observation, 2004).
Further functional study of the corneal epithelium, using the
CCR6-KO mouse and a neutralizing Ab to MIP-3 should be
undertaken Second, given the complex redundancy of the
chemokine receptor–ligand systems, we were unable to iden-
tify specifically whether both RANTES and MIP-1 or a ligand
alone are involved in the recruitment of corneal LCs. Finally,
we have recently identified a highly immature/precursor LC
population in the corneal epithelium.2,43 Although our data do
not differentiate between the role of the CCR5 chemokine
system in the mobilization of these resident immature LCs
(none of the highly immature Ia-negative LCs express CCR5)
and the novel recruitment of LCs into the epithelium, we
cannot rule out that CCR5, or its associated ligands, may im-
pact these resident cells indirectly. This is highly unlikely,
because the role of CCR5, so far, has been limited to the
chemotaxis of APCs and not to their maturation or sensitiza-
tion.37–38
Herein we provide data, for the first time that specifically
identify the role of CCR5 in initiating the mobilization of LCs to
the cornea. Our data suggest that CCR5 and its associated
ligands play a critical role in mediating the recruitment and
mobilization of MHC class II LCs into the corneal epithelium.
Targeting the CCR5 chemokine system may serve as an appro-
FIGURE 6. Immunohistochemical studies by confocal microscopy.
(A–C) On day 6 after cautery, CD45 dendritiform LCs (red) expressed
CCR5 (green) in the corneal epithelium. (A) CD45 (red), (B) CCR5
(green), (C) merger of (A) and (B), costained (yellow). (D) MHC class
II LCs (green) as shown in (D) did not express CCR5 (red; E). On day
6 after cautery, LCs expressing CD80 (red; F) did not express CCR5
(green) in the corneal epithelium.
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priate model for the prevention or treatment of corneal inflam-
mation like in microbial keratitis or allograft rejection.
References
1. Williamson JSP, DiMarco S, Streilein JW. Immunobiology of Lang-
erhans cells on the ocular surface. Invest Ophthalmol Vis Sci.
1987;28:1527–1532.
2. Hamrah P, Zhang Q, Liu Y, Dana MR. Novel characterization of
MHC class II-negative population of resident corneal Langerhans
cell-type dendritic cells. Invest Ophthalmol Vis Sci. 2002;43:639–
646.
3. Gillette TE, Chandler JW, Greiner JV. Langerhans cells of the ocular
surface. Ophthalmology. 1982;89:700–711.
4. Dekaris I, Zhu S, Dana MR. TNF- regulates corneal Langerhans cell
migration. J Immunol. 1999;162:4235–4239.
5. Dana MR, Dai R, Zhu S, Yamada J, Streilein JW. Interleukin-1
receptor antagonist suppresses Langerhans cell activity and pro-
motes ocular immune privilege. Invest Ophthalmol Vis Sci. 1998;
39:70–77.
6. Jager MJ, Gregerson DS, Streilein JW. Regulators of immunological
responses in the cornea and the anterior chamber of the eye. Eye.
1995;9:241–246.
7. McLeish W, Rubsamen P, Atherton SS, Streilein JW. Immunobiol-
ogy of Langerhans cells on the ocular surface. II. Role of central
corneal Langerhans cells in stromal keratitis following experimen-
tal HSV-1 infection in mice. Reg Immunol. 1989;2:236–243.
8. Asbell PA, Kamenar T. The response of Langerhans cells in the
cornea to herpetic keratitis. Curr Eye Res. 1987;6:179–182.
9. Miller JK, Laycock KA, Nash MM, Pepose JS. Corneal Langerhans
cell dynamic after herpes simplex virus reactivation. Invest Oph-
thalmol Vis Sci. 1993;34:2282–2290.
10. Hazlett LD, Moon MM, Dawisha S, Berk RS. Age alters ADPase
positive dendritic (Langerhans) cell response to P. aeruginosa
ocular challenge. Curr Eye Res. 1986;5:343–355.
11. Jager MJ, Bradley D, Atherton S, Streilein JW. Presence of Langer-
hans cells in the central cornea linked to the development of
ocular herpes in mice. Exp Eye Res. 1992;54:835–841.
12. Hazlett LD, McClellan SA, Rudner XL, Barrett RP. The role of
Langerhans cells in Pseudomonas aeruginosa infection. Invest
Ophthalmol Vis Sci. 2002;43:189–197.
13. Sano Y, Ksander BR, Streilein JW, Minor H, rather than MHC,
alloantigens offer the greater barrier to successful orthotopic cor-
neal transplantation in mice. Transpl Immunol. 1996;4:53–56.
14. Sano Y, Ksander BR, Streilein JW. Murine orthotopic corneal trans-
plantation in high-risk eyes: rejection is dictated primarily by weak
rather than strong alloantigens. Invest Ophthalmol Vis Sci. 1997;
38:1130–1138.
15. Streilein JW. Immunobiology and immunopathology of corneal
transplantation. Chem Immunol. 1999;73:186–206.
16. Dana MR, Yamada J, Streilein JW. Topical interleukin 1 receptor
antagonist promotes corneal transplant survival. Transplantation.
1997;63:1501–1507.
17. Niederkorn JY, Peeler JS, Mellon J. Phagocytosis of particulate
antigens by corneal epithelial cells stimulate interleukin-1 secre-
tion and migration of Langerhans cells into the central cornea. Reg
Immunol. 1989;2:83–90.
18. Niederkorn JY. Effects of cytokine-induced migration of Langer-
hans cells on corneal allograft survival. Eye. 1995;9:215–218.
19. Cumberbatch M, Dearman RJ, Kimber I. Langerhans cells require
signals from both tumour necrosis factor-alpha and interleukin-1
beta for migration. Immunology. 1997;92:388–395.
20. Cumberbatch M, Kimber I. Tumor necrosis factor-alpha is required
for accumulation of dendritic cells in draining lymph nodes and for
optimal contact sensitization. Immunology. 1995;84:31–35.
21. Wang B, Kondo S, Shivji GM, Fujisawa H, Mak TW, Sauder DN.
Tumor necrosis factor receptor II (p75) signaling is required for
the migration of Langerhans cells. Immunology. 1996;88:284–
288.
22. Gerard C, Frossard JL, Bhatia M, et al. Targeted disruption of the
beta-chemokine receptor CCR1 protects against pancreatitis-asso-
ciated lung injury. J Clin Invest. 1997;100:2022–2207.
23. Yamagami S, Miyazaki D, Ono S, Dana MR. Differential chemokine
gene expression after corneal transplantation. Invest Ophthalmol
Vis Sci. 1999;40:2892–2897.
24. Yamada J, Dana MR, Zhu SN, Alard P, Streilein JW. Interleukin 1
receptor antagonist suppresses allosensitization in corneal trans-
plantation. Arch Ophthalmol. 1998;116:1351–1357.
25. Qian Y, Dekaris I, Yamagami S, Dana MR. Topical soluble tumor
necrosis factor receptor type I suppresses ocular chemokine gene
expression and rejection of allogeneic corneal transplants. Arch
Ophthalmol. 2000;118:1666–1671.
26. Hamrah P, Liu Y, Zhang Q, Dana MR. The corneal stroma is
endowed with significant numbers of resident dendritic cells.
Invest Ophthalmol Vis Sci. 2003;44:581–589.
27. Hamrah P, Liu Y, Zhang Q, Dana MR. Alterations in corneal stromal
dendritic cell phenotype and distribution in inflammation. Arch
Ophthalmol. 2003;121:1132–1140.
28. Luster AD. Chemokines-chemotactic cytokines that mediate in-
flammation. N Engl J Med. 1998;338:436–445.
29. Ward SG, Bacon K, Westwick J. Chemokines and T lymphocytes:
more than an attraction. Immunity. 1998;9:1–11.
30. Springer TA. Traffic signals for lymphocyte recirculation and leu-
kocyte emigration: the multistep paradigm. Cell. 1994;76:301–314.
31. Yanagihara S, Komura E, Nagafune J, Watarai H, Yamaguchi Y.
EBI1/CCR7 is a new member of dendritic cell chemokine receptor
that is up-regulated upon maturation. J Immunol. 1998;161:3096–
3102.
32. Dieu-Nosjean MC, Massacrier C, Homey B, et al. Macrophage
inflammatory protein 3alpha is expressed at inflamed epithelial
surfaces and is the most potent chemokine known in attracting
Langerhans cell precursors. J Exp Med. 2000;192:705–718.
33. Rubbert A, Combadiere C, Ostrowski M, et al. Dendritic cells
express multiple chemokine receptors. J Immunol. 1998;160:
3933–3941.
34. Dieu-Nosjean MC, Vicari A, Lebecque S, Caux C. Regulation of
dendritic cell trafficking: a process that involves the participation
of selective chemokines. J Leukoc Biol. 1999;66:252–262.
35. Sato K, Kawasaki H, Nagayama H, et al. Signaling events following
chemokine receptor ligation in human dendritic cells at different
developmental stages. Int Immunol. 2001;13:167–179.
36. Charbonnier AS, Kohrgruber N, Kriehuber E, Stingl G, Rot A,
Maurer D. Macrophage inflammatory protein 3alpha is involved in
the constitutive trafficking of epidermal Langerhans cells. J Exp
Med. 1999;190:1755–1768.
37. Sallusto F, Palermo B, Lenig D, et al. Distinct patterns and kinetics
of chemokine production regulate dendritic cell function. Eur
J Immunol. 1999;29:1617–1625.
38. Combadiere C, Ahuja SK, Tiffany HL, Murphy PM. Cloning and
functional expression of CC CKR5, a human monocyte CC che-
mokine receptor selective for MIP-1 (alpha), MIP-1 (beta), and
RANTES. J Leukoc Biol. 1996;60:147–152.
39. Samson M, Labbe O, Mollereau C, Vassart G, Parmentier M. Mo-
lecular cloning and functional expression of a new human CC-
chemokine receptor gene. Biochemistry. 1996;35:3362–3367.
40. Fan L, Reilly CR, Luo Y, Dorf ME, Lo D. Ectopic expression of the
chemokine TCA4/SLC is sufficient to trigger lymphoid neogenesis.
J Immunol. 2000;164:3955–3959.
41. Carramolino L, Kremer L, Goya I, et al. Down-regulation of the
beta-chemokine receptor CCR6 in dendritic cells mediated by
TNF-alpha and IL-4. J Leukoc Biol. 1999;66:837–844.
42. Iwasaki A, Kelsall BL. Localization of distinct Peyer’s patch den-
dritic cell subsets and their recruitment by chemokines macro-
phage inflammatory protein (MIP)-3alpha, MIP-3beta, and second-
ary lymphoid organ chemokine. J Exp Med. 2000;191:1381–1394.
43. Liu Y, Hamrah P, Zhang Q, Taylor AW, Dana MR. Draining lymph
nodes of corneal transplant hosts exhibit evidence for donor major
histocompatibility complex (MHC) class II-positive dendritic cells
derived from MHC class II-negative grafts. J Exp Med. 2002;195:
259–268.
IOVS, April 2005, Vol. 46, No. 4 CCR5 Mediates Recruitment of Langerhans Cells 1207
Downloaded From: http://iovs.arvojournals.org/pdfaccess.ashx?url=/data/journals/iovs/932933/ on 06/18/2017
